2Te HS, Schiano TD, Kuan SF, et al. Hepatic effects of longterm methotrexate use in thereatment of inflammatory bowel disease [ J ]. Am J Gastroenterol,2000,95 (11) :3150-3153.
3Comeau TB, Phillips DL. Chemotherapy Dosing with Elevated LiverFunction Test Results in Acute Leukemia. The Annals of Pharmaco-therapy, 2005,39:1752-1754.
4Lee JY, Lee WS, Jung MK, et al. Acute myeloid leukemia presentingas obstructive jaundice caused by granulocytic sarcoma. Gut Liver,2007, 1:182-185.
5Patel KJ, Latif SU, de Calaca WM. An unusual presentation erf" precursorT cell lymphoblastic leukemia/lymphoma with cholestatic jaundice:case report. J Hematol Oncol,2009, 2: 12.
6Daniel SV, Vani DH, Smith AM, et al. Obstructive jaundice due toa pancreatic mass : a rare presentation of acute lymphoblastic leukaemiain an adult. JOP, 2010, 11 :72-74.
7Siddique MN,Popalzai M,Aoun N, et al. Precursor B-cell acutelymphoblastic leukemia presenting as obstructive jaundice: a casereport . Journal of Medical Case Reports,2011, 5:269.
8Tallman MS, Abutalib SA, Altman JK. The double hazard ofthrombophilia and bleeding in acute promyelocytic leukemia. SeminThromb Hemost, 2007 , 33:330-338.
9Kato I, Niwa A, Heike T, et al. Identification of Hepatic NicheHarboring Human Acute Lymphoblastic Ijeukemic Cells via the SDF-1/CXCR4 Axis. PLoS ONE, 2011, 6:142.
10Chen CY, Chen YC, Tang JL,et al. Hepatosplenic fungal infectionin patients with acute leukemia in Taiwan : incidence, treatment,and prognosis. Ann Hematol, 2003 , 82:93-94.
